Schumer moves forward on Medicare drug price negotiations with Manchin's support — reports

Months after Sen. Joe Manchin (D-WV) essentially squashed Democrats’ hopes of passing the Build Back Better Act, which included proposals to lower drug prices, a second attempt is reportedly underway that passes muster with all Senate Democrats.

First reported by Punchbowl, Senate Majority Leader Chuck Schumer (D-NY) is submitting a potential reconciliation package to the Senate parliamentarian that includes an agreement backed by all 50 Senate Democrats, including Manchin, to allow Medicare to negotiate prescription drug costs.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

BECOME A PREMIUM SUBSCRIBER

Schumer moves forward on Medicare drug price negotiations with Manchin's support — reports

Paul Schloesser

Associate Editor

Nicole DeFeudis

Editor

Unlock this article instantly by becoming a free subscriber.

Bristol Myers to shutter Bay Area cell therapy R&D facility as it eliminates jobs and costs

The next generation of AI biotechs is here. Can they deliver on the hype?

AbbVie beats first-quarter expectations, but Humira guidance leaves analysts confused

Sanders presses pharma leaders to change stance on Pandemic Accord proposals

Updated: FDA approves Pfizer’s hemophilia B gene therapy, with $3.5M price tag

UCB makes major management changes; Bristol Myers’ ADC partner tops list of new CEOs

Schumer moves for­ward on Medicare drug price ne­go­ti­a­tions with Manch­in's sup­port — re­ports

Associate Editor

Editor

Unlock this article instantly by becoming a free subscriber.

more like this

Schumer moves forward on Medicare drug price negotiations with Manchin's support — reports